The United States has supplied doses of an experimental Ebola treatment to support clinical trials in the Democratic Republic of Congo (DRC), as health authorities work to contain a growing outbreak of the deadly virus. According to US health officials, the antibody-based treatment developed by Mapp Biopharmaceutical will be used in ongoing clinical studies and
Read full story on Daily Times – Latest Pakistan News, World, Busines



